ORIC PHARMACEUTICALS, INC. (ORIC)

SEC filing

ORIC PHARMACEUTICALS, INC.

ORIC · CIK 1796280

4 · Oct 2, 2026 · Director Heyman Richard A. sold 6,700 shares at $12.91/share ($86,524); exercised options for 7,000 shares

Director Heyman Richard A. sold 6,700 shares at $12.91/share ($86,524); exercised options for 7,000 shares

Could not load the primary document from EDGAR (SEC rate limit, timeout, or temporary upstream error). Refresh in a minute, or use View on SEC.gov.